Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3225 of 3284 entries
View as:

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

Phase: N/A Priority: Normal
NCT ID: NCT04600505 Org: User:
Start: 10/19/20 End: 05/17/21 Due: 05/17/22

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Phase: N/A Priority: Normal
NCT ID: NCT01095653 Org: User:
Start: 06/30/10 End: 03/31/12 Due: 03/31/13

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT02226198 Org: User:
Start: 11/30/14 End: 07/31/15 Due: 07/31/16

Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01514240 Org: User:
Start: 02/29/12 End: 09/30/14 Due: 09/30/15

Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in Russia

Phase: N/A Priority: Normal
NCT ID: NCT06414746 Org: User:
Start: 12/29/23 End: 06/30/25 Due: 06/30/26

Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses

Phase: N/A Priority: Normal
NCT ID: NCT00841048 Org: User:
Start: 02/28/09 End: 05/31/09 Due: 05/31/10

DIabetic Retinopathy Candesartan Trials

Phase: N/A Priority: Normal
NCT ID: NCT00252694 Org: User:
Start: 08/31/01 End: 04/30/08 Due: 04/30/09

Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01509677 Org: User:
Start: 02/01/12 End: 02/01/16 Due: 02/01/17

TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial

Phase: N/A Priority: Normal
NCT ID: NCT00227318 Org: User:
Start: 07/31/98 End: 10/31/05 Due: 10/31/06

Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT03199053 Org: User:
Start: 10/11/17 End: 01/03/24 Due: 01/03/25

Adult Bipolar Mania

Phase: N/A Priority: Normal
NCT ID: NCT00931723 Org: User:
Start: 06/30/09 End: 11/30/10 Due: 11/30/11

Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222

Phase: N/A Priority: Normal
NCT ID: NCT04877743 Org: User:
Start: 05/31/21 End: 11/24/21 Due: 11/24/22

Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years

Phase: N/A Priority: Normal
NCT ID: NCT02725593 Org: User:
Start: 06/22/16 End: 04/06/20 Due: 04/06/21

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium

Phase: N/A Priority: Normal
NCT ID: NCT00808678 Org: User:
Start: 12/31/08 End: - Due: -

A Study of Andexanet Alfa in Patients Requiring Urgent Surgery or Procedure

Phase: N/A Priority: Normal
NCT ID: NCT05926349 Org: User:
Start: 08/02/24 End: 09/07/27 Due: 09/07/28

Study to Investigate Safety, Tolerability and Pharmacokinetics With Single and Multiple Ascending Doses of AZD1446

Phase: N/A Priority: Normal
NCT ID: NCT00902993 Org: User:
Start: 04/30/09 End: 09/30/09 Due: 09/30/10

Comparison Study of a New Combination of 2 Marketed Medications (Esomeprazole and Naprosyn) Versus Naprosyn Alone

Phase: N/A Priority: Normal
NCT ID: NCT00992381 Org: User:
Start: 09/30/09 End: 10/31/09 Due: 10/31/10

PPI Sequencing Study

Phase: N/A Priority: Normal
NCT ID: NCT00384592 Org: User:
Start: 09/30/06 End: 05/31/07 Due: 05/31/08

A Study to Assess the Relative Bioavailability of Process Variants of Selumetinib in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02322749 Org: User:
Start: 02/28/15 End: 04/30/15 Due: 04/30/16

Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

Phase: N/A Priority: Normal
NCT ID: NCT01081509 Org: User:
Start: 03/31/10 End: 10/31/11 Due: 10/31/12

Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01904773 Org: User:
Start: 08/31/13 End: 02/28/15 Due: 02/28/16

Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02224053 Org: User:
Start: 09/30/14 End: 01/31/15 Due: 01/31/16

Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT01203917 Org: User:
Start: 09/30/10 End: 06/30/16 Due: 06/30/17

Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk

Phase: N/A Priority: Normal
NCT ID: NCT01781416 Org: User:
Start: 11/30/13 End: 04/30/14 Due: 04/30/15

A Study of Adavosertib as Treatment for Uterine Serous Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04590248 Org: User:
Start: 11/30/20 End: 02/07/23 Due: 02/07/24